Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model

Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors

(2010) Barbara Seliger et al.   TRENDS IN MOLECULAR MEDICINE

Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells

(2009) H. Xin et al.   CANCER RESEARCH

Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma

(2009) David Aguiar Bujanda et al.   Clinical & Translational Oncology

Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma

(2009) H. Huynh et al.   CURRENT CANCER DRUG TARGETS

Identification of a Novel DNA Binding Site and a Transcriptional Target for Activating Transcription Factor 5 in C6 Glioma and MCF-7 Breast Cancer Cells

(2009) G. Li et al.   MOLECULAR CANCER RESEARCH

The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling

(2009) L Lin et al.   ONCOGENE

QS299. MTD2 Mice Provide an Excellent Model for in Vivo Adoptive Transfer Studies to Evaluate the Tumor Antigen Specific T Cell Response to Hepatocellular Cancer

(2008) Luis Garcia et al.   JOURNAL OF SURGICAL RESEARCH

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute